Finnish outpatient group Terveystalo is working with businesses to create COVID-19 action plans as economies start to open. Meanwhile, corporate and private pay is down 30% in April.
Nordic care groups Unicare and Norlandia are handing their for-profit nursing homes in Norway to not-for-profits or municipalities because the latter refuses to work with the private sector.
Belgium, where health ministry figures show 53% of the country's 7,594 COVID-19 deaths have occurred in care homes is mass-testing all residents and has already completed over 100,000 tests. We are told that there are some surprising results. The aim is to enable homes to build COVID-free operations so that they can start replenishing.
Sistema, the conglomerate which owns Russia's largest private healthcare group Medsi, has developed a test through its biotech arm which can be rolled out across Medsi's clinics. It may be one of the only major private healthcare providers anywhere which is under the same ownership umbrella as a biotech company developing new tests.
Italy's largest private hospital operator Gruppo San Donato (GSD) has raised a €265m loan from five Italian banks to go towards the construction of its new 16-story hospital in Milan.
Anecdotally, care homes across Europe are 'the new epicentre' of the coronavirus but most states still don't have any grasp on how much of the sector is infected. HBI collates reports to assess what the real impact of the coronavirus is across Western Europe. It suggests that rates could be under-reported by 80%.
Patient footfall for outpatient care across the world has all but stopped. Exclusive data from DocPlanner shows which specialities have seen the biggest drop in appointments booked and where telemedicine is really picking up some of the slack. We assess this against outpatient volumes in Singapore during SARS to see when it might pick up.
Cancer companies in the UK do not have a contract with the NHS to take 20,000 public patients, despite an earlier report to the contrary in a UK broadsheet newspaper. Providers tell HBI that they fear that a mass of 'second-wave deaths' and look at how pressure might transform clinical pathways in oncology.
The founder of EMEA hospital group Mediclinic, Dr Edwin Hertzog, will be replaced as chair of the company board in July, 37 years after he founded the company. What does the choice of replacement signify for the future of the company?
We hear from Dario Beretta, who heads up the private hospital association of Lombardy. The region in north Italy has been battling a ferocious COVID-19 outbreak and is by far the worst-hit part of Europe. Beretta is also the general director the San Siro Clinical Institute in Milan, part of the country's largest private hospital operator Gruppo San Donato (GSD).
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
